Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast and Nasal Budesonide for Mild OSA in Adults
NCT01089647Phase 3Completed
- Sponsor
- Romaker & Associates
- Start
- Sep 2010
- Primary completion
- Jun 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of montelukast, EPI-EE in obstructive sleep apnea (OSA), sponsored by Romaker & Associates. Started Sep 2010; status: completed.
02
Drugs
montelukastEPI-EE
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT01089647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01089647.